RVMDW · Revolution Medicines, Inc. · Investor Relations
$8.85
-0.52 (-5.55%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$40.08B
Shares
214.34M
Volume · Oct 26
18.53K
Avg daily vol (3M)
39.62K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-04 21:30 UTC | Revolution Medicines Q3 2026 Earnings Conference Call | Earnings call |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-26 | RASONQUE FDA Approval Investor Update | Event |
| 2026-08-05 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-31 | Revolution Medicines Conference Call | Conference |
| 2026-05-06 | Revolution Medicines Q1 2026 Earnings Conference Call | Earnings call |
| 2026-02-25 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.revmed.com/